Results for Biogen insufficiency
Benefits and pitfalls of functional patent claims (and why the UK is out of step with the EPO on claim construction): Astellas v Teva [2023] EWHC 2571 (Pat) Benefits and pitfalls of functional patent claims (and why the UK is out of step with the EPO on claim construction): Astellas v Teva [2023] EWHC 2571 (Pat) Reviewed by Dr Rose Hughes on Monday, November 06, 2023 Rating: 5
FibroGen v. Akebia: Arnold LJ addresses insufficiency, equivalence, second medical use claims, and much more FibroGen v. Akebia: Arnold LJ addresses insufficiency, equivalence, second medical use claims, and much more Reviewed by Léon Dijkman on Saturday, April 25, 2020 Rating: 5
A case for our times: Ambiguity, insufficiency and uncertainty (Anan Kasei v Neo [2019] EWCA Civ 1646) A case for our times: Ambiguity, insufficiency and uncertainty (Anan Kasei  v Neo [2019] EWCA Civ 1646) Reviewed by Dr Rose Hughes on Friday, November 01, 2019 Rating: 5
Court of Appeal, following EPO, reverses Carr J in Regeneron v Kymab dispute Court of Appeal, following EPO, reverses Carr J in Regeneron v Kymab dispute Reviewed by Annsley Merelle Ward on Wednesday, March 28, 2018 Rating: 5
Canadian Supreme Court holds promise doctrine "unsound" in AstraZeneca v Apotex Nexium dispute Canadian Supreme Court holds promise doctrine "unsound" in AstraZeneca v Apotex Nexium dispute Reviewed by Annsley Merelle Ward on Saturday, July 01, 2017 Rating: 5
Gilead triumphant as Court of Appeal upholds Arnold J in Idenix's Sovaldi appeal Gilead triumphant as Court of Appeal upholds Arnold J in Idenix's Sovaldi appeal Reviewed by Annsley Merelle Ward on Monday, November 14, 2016 Rating: 5
Biogen, Lundbeck, Lord Hoffmann and a tour de force Biogen, Lundbeck, Lord Hoffmann and a tour de force Reviewed by Jeremy on Wednesday, February 25, 2009 Rating: 5
More than the patentee deserves? No problem ... More than the patentee deserves? No problem ... Reviewed by Jeremy on Thursday, April 10, 2008 Rating: 5
Powered by Blogger.